We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Open Drawer MenuClose Drawer Menu
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine
Review

Prospects for nanomedicine in treating age-related macular degeneration

    Yasuhiro Tamaki

    Department of Ophthalmology, University of Tokyo School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.

    Search for more papers by this author

    Email the corresponding author at tamaki-tky@umin.ac.jp

    Published Online:30 Mar 2009https://doi.org/10.2217/nnm.09.10

    Abstract

    Polyion complex (PIC) micelles have a size range of tens of nanometers formed through electrostatic interaction. In experimental choroidal neovascularization (CNV) in rats, the PIC micelle accumulates to the CNV lesions and is retained. PIC micelles can be used for effective drug delivery to CNV. A novel dendritic photosensitizer encapsulated by a polymeric-micelle formulation was employed for an effective photodynamic therapy for age-related macular degeneration. With its highly selective accumulation on experimental CNV lesions, this treatment resulted in a remarkably efficacious CNV occlusion with minimal unfavorable phototoxicity. Gene therapy is a promising approach to treat age-related macular degeneration. A ternary complex, composed of a core containing DNA packaged with cationic peptides and enveloped in the anionic dendrimer phthalocyanine, has been developed, which provides the photosensitizing action. Subconjunctival injection of the ternary complex followed by laser irradiation resulted in transgene expression only in the laser-irradiated site in rats.

    Bibliography

    • 1  Ferris FL, Fine SL, Hyman L: Age-related macular degeneration and blindness due to neovascular maculopathy. Arch. Ophthalmol.102,1640–1642 (1984).
      MedlineGoogle Scholar
    • 2  Bressler NM, Bressler SB, Fine SL: Age-related macular degeneration. Surv. Ophthalmol.32,375–413 (1988).
      Medline CASGoogle Scholar
    • 3  The Eyetech study group. Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration. Phase II study results. Ophthalmology110,979–986 (2003).
      MedlineGoogle Scholar
    • 4  Heier JS, Antoszyk AN, Pavan PR et al.: Ranibizumab for treatment of neovascular age-related macular degeneration: a Phase I/II multicenter, controlled, multidose study. Ophthalmology113,633–642 (2006).
      MedlineGoogle Scholar
    • 5  Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials – TAP report. Arch. Ophthalmol.117,1329–1345 (1999).
      MedlineGoogle Scholar
    • 6  Shen J, Samul R, Silva RL et al.: Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1. Gene Ther.13,225–234 (2006).
      Medline CASGoogle Scholar
    • 7  Kimura H, Yasukawa T, Tabata Y et al.: Drug targeting to choroidal neovascularization. Adv. Drug Deliv. Rev.52,79–91 (2001).
      Medline CASGoogle Scholar
    • 8  Kataoka K, Harada A, Nagasaki Y: Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv. Drug Deliv. Rev.47,113–131 (2001).
      Medline CASGoogle Scholar
    • 9  Kakizawa Y, Kataoka K: Block copolymer micelles for delivery of gene and related compounds. Adv. Drug Deliv. Rev.54,203–222 (2002).
      Medline CASGoogle Scholar
    • 10  Matsumura Y, Maeda H: A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res.46,6387–6392 (1986).
      Medline CASGoogle Scholar
    • 11  Nakanishi T, Fukushima S, Okamoto K, et al.: Development of the polymer micelle carrier system for doxorubicin. J. Control. Release74,295–302 (2001).
      Medline CASGoogle Scholar
    • 12  Nishiyama N, Kato Y, Sugiyama Y et al.: Cisplatin-loaded polymer-metal complex micelle with time-modulated decaying property as a novel drug delivery system. Pharm. Res.18,1035–1041 (2001).
      Medline CASGoogle Scholar
    • 13  Harada A, Kataoka K: Formation of polyion complex micelles in an aqueous milieu from a pair of oppositely-charged block copolymers with poly(ethylene glycol) segments. Macromolecules2,5294–5299 (1995).
      Google Scholar
    • 14  Yanagi Y, Tamaki Y, Obata R et al.: Subconjunctival administration of bucillamine suppresses choroidal neovascularization in rat. Invest. Ophthalmol. Vis. Sci.43,3495–3499 (2002).
      MedlineGoogle Scholar
    • 15  Yanagi Y, Tamaki Y, Inoue Y et al.: Subconjunctival doxifluridine administration suppresses rat choroidal neovascularization through activated thymidine phosphorylase. Invest. Ophthalmol. Vis. Sci.44,751–754 (2003).
      MedlineGoogle Scholar
    • 16  Yasukawa T, Kimura H, Tabata Y et al.: Targeted delivery of antiangiogenic agent TNP-470 using water-soluble polymer in the treatment of choroidal neovascularization. Invest. Ophthalmol. Vis. Sci.40,2690–2696 (1999).
      Medline CASGoogle Scholar
    • 17  Harada A, Kataoka K: Pronounced activity of enzymes through the incorporation into the core of polyion complex micelles made from charged block copolymers. J. Control. Release72,85–91 (2001).
      Medline CASGoogle Scholar
    • 18  Harada-Shiba M, Yamauchi K, Harada A et al.: Polyion complex micelles as vectors in gene therapy – pharmacokinetics and in vivo gene transfer. Gene Ther.9,407–414 (2002).
      Medline CASGoogle Scholar
    • 19  Harada A, Togawa H, Kataoka K: Physicochemical properties and nuclease resistance of antisense-oligodeoxynucleotides entrapped in the core of polyion complex micelles composed of poly(ethylene glycol)-poly(L-lysine) block copolymers. Eur. J. Pharm. Sci.13,35–42 (2001).
      Medline CASGoogle Scholar
    • 20  Ideta R, Yanagi Y, Tamaki Y et al.: Effective accumulation of polyion complex micelle to experimental choroidal neovascularization in rats. FEBS Lett.557,21–25 (2004).
      Medline CASGoogle Scholar
    • 21  Meads C, Hyde C: Photodynamic therapy with verteporfin is effective, but how big is its effect? Results of a systematic review. Br. J. Ophthalmol.88,212–217 (2004).
      Medline CASGoogle Scholar
    • 22  Ideta R, Tasaka F, Jang WD et al.: Nanotechnology-based photodynamic therapy for neovascular disease using a supramolecular nanocarrier loaded with a dendritic photosensitizer. Nano Lett.5,2426–2431 (2005).
      Medline CASGoogle Scholar
    • 23  Campochiaro PA, Nguyen QD, Shah SM et al.: Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a Phase I clinical trial. Hum. Gene Ther.17,167–176 (2006).
      Medline CASGoogle Scholar
    • 24  Ogris M, Wagner E: Targeting tumors with nonviral gene delivery systems. Drug Discov. Today7,479–485 (2002).
      Medline CASGoogle Scholar
    • 25  Conwell CC, Huang L: Recent progress in non-viral gene therapy. In: Non-viral Gene Therapy: Gene Design and Delivery. Taira K, Kataoka K, Niidome T (Eds). Springer-Verlag, Tokyo 3–10 (2005).
      Google Scholar
    • 26  Merdan T, Kopecek J, Kissel T: Prospects for cationic polymers in gene and oligonucleotide therapy against cancer. Adv. Drug Deliv. Rev.54,715–758 (2002).
      Medline CASGoogle Scholar
    • 27  Salem AK, Searson PC, Leong KW: Multifunctional nanorods for gene delivery. Nat. Mater.2,668–671 (2003).
      Medline CASGoogle Scholar
    • 28  Behr JP: The proton sponge. A trick to enter cells the viruses did not exploit. Chimia51,34–36 (1997).
      CASGoogle Scholar
    • 29  Hogest A, Prasmickaite L, Tjelle TE et al.: Photochemical transfection: a new technology for light-induced, site-directed gene delivery. Hum. Gene Ther.11,869–880 (2000).
      MedlineGoogle Scholar
    • 30  Hogest A, Prasmickaite L, Selbo PK et al.: Photochemical internalization in drug and gene delivery. Adv. Drug Deliv. Rev.56,95–115 (2004).
      MedlineGoogle Scholar
    • 31  Rudolph C, Plank C, Lausier J et al.: Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells. J. Biol. Chem.278,11411–11418 (2003).
      Medline CASGoogle Scholar
    • 32  Miyata K, Kakizawa Y, Nishiyama N et al.: Block catiomer polyplexes with regulated densities of charge and disulfide cross-linking directed to enhance gene expression. J. Am. Chem. Soc.126,2355–2361 (2004).
      Medline CASGoogle Scholar
    • 33  Lee M, Rents J, Bikram M et al.: Hypoxia-inducible VEGF gene delivery to ischemic myocardium using water-soluble lipopolymer. Gene Ther.10,1535–1542 (2003).
      Medline CASGoogle Scholar
    • 34  Stackhouse MA, Buchsbaum DJ: Radiation to control gene expression. Gene Ther.7,1085–1086 (2000).
      Medline CASGoogle Scholar
    • 35  Daiger SP: Was the human genome project worth the efforts? Science308,362–364 (2005).
      Medline CASGoogle Scholar
    • 36  Nishiyama K, Iriyama A, Jang WD et al.: Light-induced gene transfer from packaged DNA enveloped in a dendrimeric photosensitizer. Nat. Mater.4,934–941 (2005).
      Medline CASGoogle Scholar